Dr. Zandberg on Biomarker Development in Head and Neck Cancer

Dan Zandberg, MD, assistant professor of medicine, the University of Maryland School of Medicine, discusses biomarker development in patients with head and neck cancer.

Biomarkers are important for determining which immunotherapy regimen a patient should receive, says Zandberg. Currently, in head and neck cancer there has not been an identified biomarker to predict response to these therapies.